Great Seal of the United States

Spokesperson Morgan Ortagus on Bolivia

27 November, 2019 | News

Transitional President Áñez & every legislator from every party in the Plurinational Legislative Assembly unanimously approved a law paving a path for new elections. This…

Great Seal of the United States

Secretary Pompeo – November 21, 2019

21 November, 2019 | News

Secretary Pompeo – November 21, 2019 All countries deserve free, fair, transparent, & credible elections. The @OAS_official report on #Bolivia makes it clear that Bolivians…

Security Alert

Security Alert: U.S. Embassy La Paz, Bolivia

13 November, 2019 | Alert

Given current civil unrest and an evolving security situation, as noted in the Travel Advisory update for Bolivia of November 12, U.S. citizens in Bolivia should depart as soon…

Great Seal of the United States

CSRA Visa Services

11 November, 2019 | Events, News

Visa appointments at U.S. Embassy La Paz for Tuesday, November 12, have been cancelled. Visa applicants will receive an email with instructions on how to…

Latest from ShareAmerica

Somalia has long been known for its poets and storytellers. Learn about a U.S.-backed program using oral traditions to help strengthen literacy there.
ShareAmerica

Somalia’s next generation of storytellers

December 10, 2019

Somalia has long been known for its poets and storytellers. Learn about a U.S.-backed program using oral traditions to help strengthen literacy there.

A U.S.-backed program is helping to get malaria medicine delivered in Niger by making sure maps accurately show the location of health facilities.
ShareAmerica

Mapping Niger to deliver malaria medicines

December 4, 2019

A U.S.-backed program is helping to get malaria medicine delivered in Niger by making sure maps accurately show the location of health facilities.

U.S. regulators have approved a California company’s new therapy for treating sickle cell disease, a painful and life-threatening inherited blood disorder.
ShareAmerica

New U.S. sickle cell drug brings hope

December 2, 2019

U.S. regulators have approved a California company’s new therapy for treating sickle cell disease, a painful and life-threatening inherited blood disorder.